This ones a heck of a specualive investment but it seems that the institutions are willing to stomp up the cash to back it in the long term.

Heres the latest news from Killik stocbrokers on the company..........

MEDICAL MARKETING Joint Venture

We recently highlighted Medical Marketing (MMG) as worthy of attention. The company, in which I have a personal share holding, has this morning announced the formation of a joint venture, Genvax, to develop a novel DNA vaccine platform technology.

Human trials have been underway since 2001 in areas such as Lymphoma and Myeloma but the technology has broad applications in cancer, viral and bacterial infections (hence the term platform). The technology works on boosting the immune system by teaching it to identify hard to recognise cancer proteins as foreign and destroy them. Early results from the 25 patient trial in lymphoma are encouraging and evaluation of the result is expected by March 2005. Successful results should mean big pharmaceutical groups will start to take financial and commercial interests around that time.

This looks to be the first of a series of announcements due from Medical Marketing as it has a range of predominantly cancer trials moving into the clinical stage. (news flow could push the price higher)

The stock has made good progress in recent sessions up to the mid-80p level where the company is valued at just under 40 million. ENDS.

Please DYOR

cheers GF.

what affect do you think the recent news will have on the company has a whole ?

RNS Number:8144C
Medical Marketing Int'l Group PLC
10 September 2004

FOR IMMEDIATE RELEASE 10TH SEPTEMBER 2004



MMI ANNOUNCES FURTHER LABHOTEL(R) PARTNER


Medical Marketing International Group plc (MMI) (LSE:MMG) the Cambridge,
UK-based biopharmaceutical development company focussed on cancer, AIDS and
'superbugs' announces that it has reached an exclusive agreement with Corbett
Research, an Australian Biotechnology company at the forefront of the
development of genetic analysis laboratory equipment, to supply its systems to
MMI's LabHotel(R).

LabHotel(R) has a unique business model as it provides fledgling biotechnology
companies based at MMI's Bioscience Innovation Centre (BIC) in Cambridge, UK,
access to sophisticated equipment managed to industrial standards on a
short-term rental basis rather than incurring capital costs. LabHotel(R) already
contains laboratories dedicated to tissue culture, microbiology and protein
purification services with further services in the pipeline.

David Best, Chairman of MMI, explained: "We are delighted that another leader,
Corbett Research is supporting our LabHotel(R). The capital cost of equipment is
often prohibitive resulting in emerging biotech companies being unable to
generate quality data that will satisfy themselves, potential partners and
investors. MMI's LabHotel(R) solves this problem by enabling the manufacturers of
world-class equipment to install their systems in a professionally managed
purpose-built centre. Through this innovative service we believe that we will
increase occupancy as well as fee levels and create greater opportunities for
MMI to take advantage of investing in these exciting businesses as well as
providing essential facilities for our in-house biobabies. Our goal is that
LabHotel(R) becomes the centre of excellence for biotechnology".

John Corbett, Director of Corbett Research commented: "This innovative approach
provides excellent opportunities for start-up companies wanting proof of
principle. The Lab Hotel is the ideal venue for us as an organisation to
showcase our latest equipment and to work with emerging companies to help them
develop new technologies"

A good deal thanks for posting it Mick.

cheers GF.

Should have a good week after a strong finishing week to techs in the US and also broker upgrades across there.

cheers GF.

How close are we to Medical Marketing shares taking off. I have been waiting for the broker update and a rapid move north this week. Any news would be much appreciated.

Jacks, Have to say it as become a little frustrating especially after a bad day on Friday.

Im sure we will get good news very soon.

cheers GF.

Still nothing but it will come.

cheers Gf.

Mitzy,

You've gone quiet, is there a problem? Are MMG still be recommended as a strong buy? If so what's happened this week?
I'm not overly worried as I've been in since March and this share is up and down like a kangaroo on a spacehopper and I also believe pipeline iis such that potentially big rewards but having topped up in recent weeks it's a tad annoying to see these in the red or more to the point could have got more this week for the same dosh!
What news on the brokers note?

Andy

No idea Andy I wish I knew but I really dont..a few sells today set off further stop losses as people panicked.We have the Agm mid Oct and a brokers note is due around about then; also results are due soon but have been delayed for some reason.Still holding for now and see what the Agm has to offer..

Keep calm ANDY.

things will GO our way.

Cheerrs GF

Medical Marketing raise 2.3 mln stg to fund product development
AFX


LONDON (AFX)- Medical Marketing International Group PLC, said it has raised 2.3 mln stg following a placing of 3.35 mln shares, at a price of 0.70 pence each.

The funds are to be used to support the clinical trials process of its products, the company said.

newsdesk@afxnews.com

Thats a lot of money to raise but they have managed to pull it off...they must be fairly confident of that oncosense will succeed in phase 2 trials.

Do you think the share price drop was "manufactured" to below 70p to allow the Institutions putting up the dosh to get a good price?
If, so is it likely to stay below 70p until the AGM approves it and if so looks like another good buying opportunity for all of us following this one.

What do you reckon?

Either way glad the drop doesn't look like bad news, you don't get 2.3m if the future is bleak!

Final Results are due next week apparently and the Agm in another 3 weeks...its all good news as far as the placing goes as it means phase 2 trials can start in ernest with the funding in position.Michael Walters has a latest post on the fundraising.

Looking good but I do think price drop might have been manipulated.
Time to top up!!

Looks like theres very good news on the Mike Walters Site...............


Clinical Trials
24/9/2004

A fund-raising by Medical Marketing means good news soon.
[Read more


cheers GF.

Unfortunately MMG showing widening FY loss today and it has gone down 5%

Medical MArketing International posted a FY pretax loss of 2.12 mln stg for the year to March 31 against a loss of 1.39 mln a year earlier.

Sales for the year were 380,314 stg compared to 461,243 stg a year earlier.

Im still a fan of this one and think that good news isnt far off, stay put I say.

cheers Gf.

Financial

Pre-exceptional loss in line with expectations
Reduction in staff and directors' costs
Year-end cash increased by 24%
Market capitalisation increased from 2m to 29m



Commenting on outlook & prospects, David Best, Executive Chairman, said:


'The prospects for the coming year are the most exciting in the Company's
history. The DNA vaccines are already in clinical trials and are expected to be
followed by products in Oncosense in the current year and by Viratis next year.
We are in advanced discussions with a number of parties concerning the further
broadening of our portfolio. Some of the proposed new funding will go towards
this objective. We intend to ensure that the investment community is made more
aware of the developments within MMI and we hope this leads not only to a
continued rise in the share price but also to a significant re-rating relative
to our peers and a consequent rise in the value of the Company.'



For further information, please contact:

David Best, Executive Chairman Tel: +44 (0)1223 477677

cheers GF.